The asparaginyl endopeptidase legumain after experimental stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 30, Issue 10, 2010, Pages 1756-1766

  Ishizaki, Taku ^a   Erickson, Agnes ^a   Kuric, Enida ^a   Shamloo, Mehrdad ^b   Hara Nishimura, Ikuko ^c   Inácio, Ana Rita Lourenço ^a   Wieloch, Tadeusz ^a   Ruscher, Karsten ^a  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

astrocyte; CD74; cerebral ischemia; legumain; microglia; poststroke inflammation

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; LEGUMAIN; B LYMPHOCYTE ANTIGEN; CYSTEINE PROTEINASE; HLA ANTIGEN CLASS 2; INVARIANT CHAIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROKE; ANIMAL; ASTROCYTE; BRAIN; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ASTROCYTES; BRAIN; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; RATS, WISTAR; STROKE;

EID: 77957695468     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.39     Document Type: Article

References (39)

1. Amantea D, Russo R, Gliozzi M, Fratto V, Berliocchi L, Bagetta G, Bernardi G, Corasaniti MT (2007) Early upregulation of matrix metalloproteinases followingreperfusion triggers neuroinflammatory mediators in brain ischemia in rat. Int Rev Neurobiol 82:149-169
2. Auer RN (2001) Non-pharmacologic (physiologic) neuroprotection in the treatment of brain ischemia. Ann NY Acad Sci 939:271-282
3. Badan I, Buchhold B, Hamm A, Gratz M, Walker LC, Platt D, Kessler C, Popa-Wagner A (2003) Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J Cereb Blood Flow Metab 23:845-854
4. Berry K, Wisniewski HM, Svarzbein L, Baez S (1975) On the relationship of brain vasculature to production of neurological deficit and morphological changes followingacute unilateral common carotid artery ligation in gerbils. J Neurol Sci 25:75-92
5. Bevers MB, Neumar RW (2008) Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab 28:655-673
6. Bryan KJ, Zhu X, Harris PL, Perry G, Castellani RJ, Smith MA, Casadesus G (2008) Expression of CD74 is increased in neurofibrillary tangles in Alzheimers disease. Mol Neurodegener 3:13
7. Campbell SJ, Finlay M, Clements JM, Wells G, Miller KM, Perry VH, Anthony DC (2004) Reduction of excitotoxicity and associated leukocyte recruitment by a broadspectrum matrix metalloproteinase inhibitor. J Neurochem 89:1378-1386
8. Chan CB, Abe M, Hashimoto N, Hao C, Williams IR, Liu X, Nakao S, Yamamoto A, Zheng C, Henter JI, Meeths M, Nordenskjold M, Li SY, Hara-Nishimura I, Asano M, Ye K (2009) Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome. Proc Natl Acad Sci USA 106:468-473
9. Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C, Barrett AJ (1997) Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem 272:8090-8098
10. Chen JM, Dando PM, Stevens RA, Fortunato M, Barrett AJ (1998) Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem J 335:111-117
11. Chen JM, Fortunato M, Stevens RA, Barrett AJ (2001) Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem 382:777-783
12. Clerin V, Shih HH, Deng N, Hebert G, Resmini C, Shields KM, Feldman JL, Winkler A, Albert L, Maganti V, Wong A, Paulsen JE, Keith Jr JC, Vlasuk GP, Pittman DD (2008) Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis. Atherosclerosis 201:53-66
13. Dietrich WD, Busto R, Valdes I, Loor Y (1990) Effects of normothermic versus mild hyperthermic forebrain ischemia in rats. Stroke 21:1318-1325
14. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston Jr LL, del Zoppo GJ (2004) Focal cerebral ischemia induces active proteases thatdegrade microvascular matrix. Stroke 35:998-1004
15. John GR, Lee SC, Brosnan CF (2003) Cytokines powerful regulators of glial cell activation. Neuroscientist 9:10-22
16. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, Le DT, Khrestchatisky M, Rivera S (2003) Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 18:1507-1517
17. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467-1476
18. Li DN, Matthews SP, Antoniou AN, Mazzeo D, Watts C (2003) Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J Biol Chem 278:38980-38990
19. Liu C, Sun C, Huang H, Janda K, Edgington T (2003) Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res 63:2957-2964
20. Maehr R, Hang HC, Mintern JD, Kim YM, Cuvillier A, Nishimura M, Yamada K, Shirahama-Noda K, Hara-Nishimura I, Ploegh HL (2005) Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. J Immunol 174:7066-7074
21. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C (1998) An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396:695-699
22. Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama- Noda K, Nishimura M, Uzu T, Hara-Nishimura I, Koya D, Kashiwagi A, Ohkubo I (2007) Legumain/ asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett 581:1417-1424
23. Nygren J, Wieloch T (2005) Enriched environment enhances recovery of motor function after focal ischemia in mice, and downregulates the transcription factor NGFI-A. J Cereb Blood Flow Metab 25:1625-1633
24. Petcu EB, Sfredel V, Platt D, Herndon JG, Kessler C, Popa-Wagner A (2008) Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review. Gerontology 54:6-17
25. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T (2008) Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab 28:551-562
26. Rickhag M,Wieloch T, Gido G, Elmer E, Krogh M, Murray J, Lohr S, Bitter H, Chin DJ, von Schack D, Shamloo M, Nikolich K (2006) Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue. J Neurochem 96:14-29
27. Rosell A, Lo EH (2008) Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 8:82-89
28. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22:10291-10301
29. Ruscher K, Johannesson E, Brugiere E, Erickson A, Rickhag M, Wieloch T (2009) Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J Cereb Blood Flow Metab 29:1796-1805
30. Sarandeses CS, Covelo G, az-Jullien C, Freire M (2003) Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase. J Biol Chem 278:13286-13293
31. Shirahama-Noda K, Yamamoto A, Sugihara K, Hashimoto N, Asano M, Nishimura M, Hara-Nishimura I (2003) Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase- deficient mice. J Biol Chem 278:33194-33199
32. Sofroniew MV (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11:400-407
33. Sottile J, Chandler J (2005) Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell 16:757-768
34. Stumptner-Cuvelette P, Benaroch P (2002) Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta 1542:1-13
35. Wen YD, Sheng R, Zhang LS, Han R, Zhang X, Zhang XD, Han F, Fukunaga K, Qin ZH (2008) Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy 4:762-769
36. Wolf PR, Ploegh HL (1995) How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 11:267-306
37. Wolk K, Grutz G, Witte K, Volk HD, Sabat R (2005) The expression of legumain, an asparaginyl endopeptidase thatcontrols antigen processing, is reduced in endotoxin- tolerant monocytes. Genes Immun 6:452-456
38. Zaremba J (2004) Hyperthermia in ischemic stroke. Med Sci Monit 10:RA148-53
39. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441-445